Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

lerisetron

The hydrochloride salt of a 2-piperazinylbenzimidazole-derivative serotonin type 3 (5-HT3) receptor antagonist with antiemetic activity. Lerisetron specifically binds to 5-HT3 receptors, located peripherally on vagus nerve terminals and centrally in the chemoreceptor trigger zone (CTZ) of the area postrema, which may result in suppression of chemotherapy-induced nausea and vomiting.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Code name:F-0930-RS2
Chemical structure:1-phenyl-methyl-2-piperazinyl-1H-benzimidazole hydrochloride
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search